Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet

Author(s):  McElhiney Linda F, Cheng Angela, Meshberger Laura, Imai Lara

Issue:  Jan/Feb 2010 - Pediatrics and Wellness
View All Articles in Issue

Page(s):  21-25

Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet Page 1
Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet Page 2
Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet Page 3
Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet Page 4
Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet Page 5

Download in electronic PDF format for $75

Abstract:  The ketogenic diet is a high-fat, lowcarbohydrate, and low-protein diet designed to increase the body’s dependence on fatty acids for energy rather than glucose. This diet is used as a treatment option for young children with refractory seizure disorders or inborn metabolic defects. Children on this diet must be closely monitored by a team of healthcare professionals consisting of neurologists, nurses, dieticians, and pharmacists. Accurate calculations for daily allowances of carbohydrates, fats, and proteins are essential for success of the treatment. Since pediatric patients that are on the ketogenic diet often take compounded medications, there is also a need to determine the carbohydrate content of the compounded medications. Researching and trying to calculate the carbohydrate content of compounded medications can be very time consuming. A group of PharmD candidates from Purdue University were provided with copies of the top 100 compounded oral liquids prepared at Clarian Health Partners, Inc. Their exte

Related Keywords: Lara Imai, children, seizure disorders, ketogenic diet, carbohydrates, metabolic disorders, glucose metabolism, excipients, oral liquid vehicles

Related Categories: EXCIPIENTS, NUTRITION AND NUTRICEUTICALS, PEDIATRICS, DOSAGE FORMS/DRUG CARRIERS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, NEUROLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet
McElhiney Linda F
, Cheng Angela, Meshberger Laura, Imai Lara
Jan/Feb 2010
Pg. 21-25

Challenges of Compounding for Patients on the Ketogenic Diet
McElhiney Linda F
Mar/Apr 2007
Pg. 116-120

Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

Oral Liquid Vehicles, Featured Excipient:
Allen Loyd V Jr
Jan/Feb 2001
Pg. 65-67

Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48

Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott
, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2010
Pg. 182-192

Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Williams LaVonn A
, Fokken Dawn
Sep/Oct 2009
Pg. 386-389

Basics of Compounding: Vehicles for Compounded Oral Liquid Medications: A Review
Cutaia Kara
, Chablani Lipika, Zhao Fang
Nov/Dec 2018
Pg. 480-489

Pediatric Compounding: Coloring Outside the Lines
Preckshot John
Jan/Feb 2001
Pg. 6-8

Compounding for Endocrine Disorders in Adult Patients
Grajeda Betty Jo
, Vail Jane
Jul/Aug 2005
Pg. 275-278

Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions
Fonseca Simonne C
Nov/Dec 2005
Pg. 456-461

Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Allen Loyd V Jr
Nov/Dec 2019
Pg. 487

Prednisolone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2020
Pg. 229

Utilization of Compounded Medications in an Oral Medicine Practice
Stock Shannon
, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
Mar/Apr 2016
Pg. 155-158

Attention Deficit Hyperactivity Disorder
Allen Loyd V Jr
Mar/Apr 1997
Pg. 87-89

Treating Inner Ear Disorders with Intratympanic Drug Administration
McElhiney Linda F
Jul/Aug 2011
Pg. 302-307

Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Urwin Craig
, Jean Linda, Carvalho Maria, Robson-Laws Michael
Nov/Dec 2022
Pg. 468-472

Compounding for Pediatric Patients: Case Reports and Formulations
Mixon William
, Angelle Patricea, Yoch Douglas
Jan/Feb 2009
Pg. 6-12

Methylphenidate in the Treatment of Attention Deficit Disorders
Tenreiro Kim
Jan/Feb 2001
Pg. 21-22

Feline Urologic Syndrome and Diet Formulation
Long Scott F
Sep/Oct 1999
Pg. 366-367

Return to Top